ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Entropy Neurodynamics Ltd
0.040
-0.001
-2.44%
成交量:
73.69萬
成交額:
3.02萬
市值:
6,524.26萬
市盈率:
-12.89
高:
0.041
開:
0.041
低:
0.040
收:
0.041
52周最高:
0.046
52周最低:
0.025
股本:
16.31億
流通股本:
8.78億
量比:
0.71
換手率:
0.08%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.003
每股收益(LYR):
-0.003
淨資產收益率:
-73.07%
總資產收益率:
-40.38%
市淨率:
8.86
市盈率(LYR):
-12.90
資料載入中...
總覽
公司
新聞
公告
Entropy Neurodynamics發布重大公告前停牌,涉及與Robin Carhart-Harris教授合作的美股二期臨床試驗
美股速递
·
08/24
Entropy Neurodynamics Ltd - 協議為Trp-8803的全球開發與商業化奠定關鍵基石
美股速递
·
08/19
Entropy Neurodynamics與TGA許可、FDA及EMA對齊的CDMO Biocina簽署戰略協議,生產TRP-8803
美股速递
·
08/19
Entropy Neurodynamics攜手斯威本科技大學,開啓全球首創臨床試驗研究合作
美股速递
·
08/04
Entropy Neurodynamics 擬在單一臨床框架下評估 Trp-8803 對八大主要病症的療效
美股速递
·
08/04
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/ENP.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ENP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ENP.AU\",,,,,undefined,":{"symbol":"ENP.AU","market":"AU","secType":"STK","nameCN":"Entropy Neurodynamics Ltd","latestPrice":0.04,"timestamp":1789107120000,"preClose":0.041,"halted":0,"volume":736898,"delay":0,"changeRate":-0.024390243902439046,"nameEN":"Entropy Neurodynamics Ltd","floatShares":878046607,"shares":1631064683,"eps":-0.003104,"marketStatus":"休市中","change":-0.001,"latestTime":"09-11 16:12:00 AEST","open":0.041,"high":0.041,"low":0.04,"amount":30198,"amplitude":0.02439,"askPrice":0.041,"askSize":250000,"bidPrice":0.04,"bidSize":100000,"shortable":3,"etf":0,"ttmEps":-0.003104,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789344000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.041,"openAndCloseTimeList":[[1789084800000,1789106400000]],"volumeRatio":0.7052894651573012,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ENP.AU","preClose":0.041,"auctionPrice":0.041,"auctionVolume":250000,"auction":3,"marketStatus":"盘后竞价","timestamp":1789106425280}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ENP.AU\",,,,,undefined,":{"symbol":"ENP.AU","floatShares":878046607,"roa":"-40.38%","roe":"-73.07%","lyrEps":-0.0031,"volumeRatio":0.7052894651573012,"shares":1631064683,"dividePrice":0,"high":0.041,"amplitude":0.02439,"preClose":0.041,"low":0.04,"week52Low":0.025,"pbRate":"8.86","psRate":"34.22","week52High":0.046,"institutionHeld":0,"latestPrice":0.04,"committee":-0.428571,"eps":-0.003104,"divideRate":0,"volume":736898,"delay":0,"ttmEps":-0.003104,"open":0.041,"prevYearClose":0.033,"prevWeekClose":0.041,"prevMonthClose":0.04,"prevQuarterClose":0.032,"fiveDayClose":0.041,"twentyDayClose":0.036,"sixtyDayClose":0.03},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENP.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENP.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENP.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1154608676","title":"Entropy Neurodynamics發布重大公告前停牌,涉及與Robin Carhart-Harris教授合作的美股二期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1154608676","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154608676?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 07:41","pubTimestamp":1787528472,"startTime":"0","endTime":"0","summary":"Entropy Neurodynamics宣布停牌,等待发布一项重要公告。该公告内容与美国二期临床试验相关,此次试验是与Robin Carhart-Harris教授合作开展的。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENP.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127786328","title":"Entropy Neurodynamics Ltd - 協議為Trp-8803的全球開發與商業化奠定關鍵基石","url":"https://stock-news.laohu8.com/highlight/detail?id=1127786328","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127786328?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 06:22","pubTimestamp":1787091728,"startTime":"0","endTime":"0","summary":"Entropy Neurodynamics Ltd - 该协议的签署,为Trp-8803在全球范围内的进一步开发与商业化推广,构筑了坚实而关键的基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ENP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157043905","title":"Entropy Neurodynamics與TGA許可、FDA及EMA對齊的CDMO Biocina簽署戰略協議,生產TRP-8803","url":"https://stock-news.laohu8.com/highlight/detail?id=1157043905","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157043905?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 06:21","pubTimestamp":1787091668,"startTime":"0","endTime":"0","summary":"Entropy Neurodynamics Limited宣布,已与Biocina签署一项战略协议。Biocina是一家持有TGA许可、并符合FDA与EMA标准的合同开发与制造组织(CDMO)。根据协议,Biocina将负责生产TRP-8803。此举标志着Entropy Neurodynamics在神经动力学领域迈出关键一步,为其候选产品的商业化供应奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENP.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152849709","title":"Entropy Neurodynamics攜手斯威本科技大學,開啓全球首創臨床試驗研究合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1152849709","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152849709?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 22:14","pubTimestamp":1785852846,"startTime":"0","endTime":"0","summary":"Entropy Neurodynamics Limited已与斯威本科技大学正式签署临床试验研究协议。此举旨在推进一项全球首创的临床试验项目,标志着神经动力学领域的研究迈入全新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ENP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192195208","title":"Entropy Neurodynamics 擬在單一臨床框架下評估 Trp-8803 對八大主要病症的療效","url":"https://stock-news.laohu8.com/highlight/detail?id=1192195208","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192195208?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 22:08","pubTimestamp":1785852503,"startTime":"0","endTime":"0","summary":"Entropy Neurodynamics 公司宣布,计划在独一的临床架构内,对旗下药物 Trp-8803 展开针对八种主要疾病的系统性评估。这一举措,旨在通过整合性的研究路径,高效地挖掘该候选药物的治疗潜力,从而为多种神经及相关疾病领域提供新的治疗方向。该研究框架的设计,力求实现跨疾病数据的同步收集与分析,以加速临床验证进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ENP.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}